Tobevibart and elebsiran for the treatment of chronic hepatitis delta.
Saved in:
| Title: | Tobevibart and elebsiran for the treatment of chronic hepatitis delta. |
|---|---|
| Authors: | Sandmann L; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany; German Center for Infection Research (DZIF), Hannover/Braunschweig, Germany. Electronic address: sandmann.lisa@mh-hannover.de. |
| Source: | Journal of hepatology [J Hepatol] 2026 Mar; Vol. 84 (3), pp. 677-678. Date of Electronic Publication: 2026 Jan 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41558882 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tobevibart and elebsiran for the treatment of chronic hepatitis delta. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sandmann+L%22">Sandmann L</searchLink>; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany; German Center for Infection Research (DZIF), Hannover/Braunschweig, Germany. Electronic address: sandmann.lisa@mh-hannover.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228503886%22">Journal of hepatology</searchLink> [J Hepatol] 2026 Mar; Vol. 84 (3), pp. 677-678. <i>Date of Electronic Publication: </i>2026 Jan 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8503886 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1600-0641 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201688278%22">01688278 </searchLink><i>NLM ISO Abbreviation: </i>J Hepatol <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41558882 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jhep.2025.12.018 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 677 Titles: – TitleFull: Tobevibart and elebsiran for the treatment of chronic hepatitis delta. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sandmann L IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2026 Mar Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1600-0641 Numbering: – Type: volume Value: 84 – Type: issue Value: 3 Titles: – TitleFull: Journal of hepatology Type: main |
| ResultId | 1 |